We are a leading healthcare campus encompassing all fields of health: from healthcare and research to teaching and management.
Professionalism, commitment and research by professionals on the Campus are the key elements in offering patients excellent care.
We are committed to research as a tool to provide solutions to the daily challenges we face in the field of medical healthcare.
We generate, transform and transmit knowledge in all areas of the health sciences, helping to train the professionals of the future.
We are defined by our vocation for communication. We invite you to share everything that happens at Vall d'Hebron Barcelona Hospital Campus, and our doors are always open.
EXIMIOUS is a project funded by the Horizon 2020 program that aims to study the exposome to understand its relationship with immune-mediated diseases.
Today, May 23, Vall d'Hebron hosted the annual meeting of researchers working on EXIMIOUS (Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome), a project funded by the European Union that involves 15 organizations from 7 European countries. EXIMIOUS aims to study the exposome, i.e. exposure to environmental factors throughout life, in order to understand its relationship with immune-mediated diseases, such as autoimmune diseases or allergies.
Exposure to different factors, related to lifestyle, occupation, stress, pollution... can have an impact on health. The precise relationship with the development of certain diseases is still unknown. "EXIMIOUS aims to combine innovative methods to characterize exposure to environmental factors and analyze the effects it causes on the immune system", explains Dr. María Jesús Cruz, head of the Pneumology group at Vall d'Hebron Research Institute (VHIR) who participates in the project together with Dr. Xavier Muñoz and predoctoral researchers David Soler and David Espejo. To do this, biological samples will be collected to analyze different markers and compare them with the places where people live and work and see if this is related to pathologies they may suffer throughout their lives.
The five-year project, starting in 2020, is funded by the European Union's Horizon 2020 program. Through new bioinformatics tools or the use of artificial intelligence, the databases of the exposome and the factors that influence the immune system and the development of certain diseases will be analyzed. Thus, it is expected to know which factors entail a higher risk of suffering some of these pathologies in order to implement preventive actions.
Vall d'Hebron is the only center in Spain participating in the project and its role lies in the recruitment of patients with hypersensitivity pneumonitis, a pathology caused by inhaling organic substances in the environment that can cause lung fibrosis. This is a rare disease for which Vall d'Hebron is a state reference center.
At the meeting held today, the progress made so far and the next steps to be taken were shared. The project is currently in an intermediate phase in which environmental measurements are being taken and patients and workers exposed to different substances are being recruited to study their effects.
Select the newsletter you want to receive:
By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to firstname.lastname@example.org, clearly stating the subject as "Exercising of Data Protection Rights".
Operated by: Vall d’Hebron University Hospital Foundation – Research Institute.
Purpose: Manage the user’s contact information.
Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use.
Source: The interested party themselves.